• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cross-reactive monoclonal antibodies to multiple HIV-1 subtype and SIVcpz envelope glycoproteins.针对多种HIV-1亚型和SIVcpz包膜糖蛋白的交叉反应性单克隆抗体。
Virology. 2009 Nov 10;394(1):91-8. doi: 10.1016/j.virol.2009.07.041. Epub 2009 Sep 9.
2
HIV-1 Consensus Envelope-Induced Broadly Binding Antibodies.HIV-1 共识包膜诱导的广泛结合抗体。
AIDS Res Hum Retroviruses. 2017 Aug;33(8):859-868. doi: 10.1089/AID.2016.0294. Epub 2017 May 30.
3
HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates.非人灵长类动物免疫接种引发的HIV-1交叉反应性原发性病毒中和抗体反应
J Virol. 2017 Oct 13;91(21). doi: 10.1128/JVI.00910-17. Print 2017 Nov 1.
4
Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody.一种新型交叉反应性1型人类免疫缺陷病毒中和性人单克隆抗体的鉴定与表征
J Virol. 2004 Sep;78(17):9233-42. doi: 10.1128/JVI.78.17.9233-9242.2004.
5
Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein.用寡聚猿猴免疫缺陷病毒包膜蛋白免疫产生的中和单克隆抗体的特性鉴定与表位作图
J Virol. 2000 Sep;74(17):7922-35. doi: 10.1128/jvi.74.17.7922-7935.2000.
6
Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies.通过筛选免疫人噬菌体文库以对抗从具有广泛HIV-1中和抗体的患者(R2)分离出的包膜糖蛋白(gp140)而选择的交叉反应性HIV-1中和单克隆抗体。
Virology. 2007 Jun 20;363(1):79-90. doi: 10.1016/j.virol.2007.01.015. Epub 2007 Feb 15.
7
SOSIP Trimer-Specific Antibodies Isolated from a Simian-Human Immunodeficiency Virus-Infected Monkey with versus without a Pre-blocking Step with gp41.与未经 gp41 预封闭步骤相比,从感染猴的 SIV 中分离出的 SOSIP 三聚体特异性抗体。
J Virol. 2022 Jan 26;96(2):e0158221. doi: 10.1128/JVI.01582-21. Epub 2021 Nov 3.
8
Antibodies from Rabbits Immunized with HIV-1 Clade B SOSIP Trimers Can Neutralize Multiple Clade B Viruses by Destabilizing the Envelope Glycoprotein.用 HIV-1 分 B 亚型 SOSIP 三聚体免疫的兔子产生的抗体可以通过破坏包膜糖蛋白来中和多种 B 亚型病毒。
J Virol. 2021 Aug 10;95(17):e0009421. doi: 10.1128/JVI.00094-21.
9
Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates.SHIV 感染诱导的抗体反应比可溶性天然 HIV-1 包膜三聚体在非人类灵长类动物中诱导的抗体反应更集中。
PLoS Pathog. 2021 Aug 25;17(8):e1009736. doi: 10.1371/journal.ppat.1009736. eCollection 2021 Aug.
10
Antigenicity and immunogenicity of transmitted/founder, consensus, and chronic envelope glycoproteins of human immunodeficiency virus type 1.人类免疫缺陷病毒 1 型传播/创始、共识和慢性包膜糖蛋白的抗原性和免疫原性。
J Virol. 2013 Apr;87(8):4185-201. doi: 10.1128/JVI.02297-12. Epub 2013 Jan 30.

引用本文的文献

1
Structural basis for GTP-induced dimerization and antiviral function of guanylate-binding proteins.G 蛋白结合蛋白的 GTP 诱导二聚化和抗病毒功能的结构基础。
Proc Natl Acad Sci U S A. 2021 Apr 13;118(15). doi: 10.1073/pnas.2022269118.
2
Mechanistic Analysis of the Broad Antiretroviral Resistance Conferred by HIV-1 Envelope Glycoprotein Mutations.HIV-1 包膜糖蛋白突变赋予广泛抗逆转录病毒耐药性的机制分析。
mBio. 2021 Jan 12;12(1):e03134-20. doi: 10.1128/mBio.03134-20.
3
HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.HIV-1 基质三聚体形成缺陷型突变体可通过增强包膜糖蛋白整合的基质取代得到挽救。
J Virol. 2019 Dec 12;94(1). doi: 10.1128/JVI.01526-19.
4
IFI16 Targets the Transcription Factor Sp1 to Suppress HIV-1 Transcription and Latency Reactivation.IFI16 通过靶向转录因子 Sp1 抑制 HIV-1 转录和潜伏再激活。
Cell Host Microbe. 2019 Jun 12;25(6):858-872.e13. doi: 10.1016/j.chom.2019.05.002. Epub 2019 Jun 4.
5
Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine.病毒样疫苗对抗 HIV/SIV 与亚优势抗原 T 细胞疫苗具有协同作用。
J Transl Med. 2019 May 24;17(1):175. doi: 10.1186/s12967-019-1924-1.
6
Single molecule fate of HIV-1 envelope reveals late-stage viral lattice incorporation.HIV-1 包膜的单分子命运揭示了晚期病毒晶格的掺入。
Nat Commun. 2018 May 10;9(1):1861. doi: 10.1038/s41467-018-04220-w.
7
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.核苷修饰的 mRNA 疫苗可诱导强烈的滤泡辅助性 T 细胞和生发中心 B 细胞反应。
J Exp Med. 2018 Jun 4;215(6):1571-1588. doi: 10.1084/jem.20171450. Epub 2018 May 8.
8
Primate lentiviruses use at least three alternative strategies to suppress NF-κB-mediated immune activation.灵长类慢病毒至少使用三种替代策略来抑制NF-κB介导的免疫激活。
PLoS Pathog. 2017 Aug 31;13(8):e1006598. doi: 10.1371/journal.ppat.1006598. eCollection 2017 Aug.
9
Development of a recombinant yellow fever vector expressing a HIV clade C founder envelope gp120.开发表达 HIV C 型始祖包膜 gp120 的重组黄热病毒载体。
J Virol Methods. 2017 Nov;249:85-93. doi: 10.1016/j.jviromet.2017.08.012. Epub 2017 Aug 31.
10
HIV-1 Consensus Envelope-Induced Broadly Binding Antibodies.HIV-1 共识包膜诱导的广泛结合抗体。
AIDS Res Hum Retroviruses. 2017 Aug;33(8):859-868. doi: 10.1089/AID.2016.0294. Epub 2017 May 30.

本文引用的文献

1
Deceptive imprinting and immune refocusing in vaccine design.疫苗设计中的欺骗性印记和免疫重定向
Vaccine. 2008 Nov 18;26(49):6189-99. doi: 10.1016/j.vaccine.2008.09.080. Epub 2008 Oct 11.
2
The challenge of HIV-1 subtype diversity.HIV-1亚型多样性的挑战。
N Engl J Med. 2008 Apr 10;358(15):1590-602. doi: 10.1056/NEJMra0706737.
3
Designing immunogens to elicit broadly neutralizing antibodies to the HIV-1 envelope glycoprotein.设计免疫原以引发针对HIV-1包膜糖蛋白的广泛中和抗体。
Curr HIV Res. 2007 Nov;5(6):514-41. doi: 10.2174/157016207782418489.
4
Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection.掩盖膜近端区域表位的1型人类免疫缺陷病毒糖蛋白41抗体:抗体结合动力学、诱导及急性感染中的调节潜力
J Virol. 2008 Jan;82(1):115-25. doi: 10.1128/JVI.00927-07. Epub 2007 Oct 17.
5
A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120.一项关于携带各种形式包膜蛋白的HIV-1病毒样颗粒、无包膜颗粒和可溶性单体gp120的比较免疫原性研究。
Virology. 2007 Sep 30;366(2):245-62. doi: 10.1016/j.virol.2007.04.033. Epub 2007 Jun 19.
6
Isolation and characterization of monoclonal antibodies elicited by trimeric HIV-1 Env gp140 protein immunogens.三聚体HIV-1包膜糖蛋白gp140免疫原引发的单克隆抗体的分离与鉴定
Virology. 2007 Sep 30;366(2):433-45. doi: 10.1016/j.virol.2007.05.020. Epub 2007 Jun 8.
7
The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes.抗体多特异性和脂质反应性在广泛中和抗HIV-1包膜人单克隆抗体2F5和4E10与糖蛋白41膜近端包膜表位结合中的作用。
J Immunol. 2007 Apr 1;178(7):4424-35. doi: 10.4049/jimmunol.178.7.4424.
8
A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120.二硫键稳定、经蛋白酶切割的可溶性三聚体人免疫缺陷病毒1型gp140、三聚体切割缺陷型gp140和单体gp120在兔体内的比较免疫原性研究
Virology. 2007 Apr 10;360(2):329-40. doi: 10.1016/j.virol.2006.10.032. Epub 2006 Nov 28.
9
Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004.2004年HIV-1基因亚型和重组体的全球及区域分布情况。
AIDS. 2006 Oct 24;20(16):W13-23. doi: 10.1097/01.aids.0000247564.73009.bc.
10
A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses.一组M型共有包膜糖蛋白可诱导产生能中和B亚型和C亚型HIV-1原代病毒亚群的抗体。
Virology. 2006 Sep 30;353(2):268-82. doi: 10.1016/j.virol.2006.04.043.

针对多种HIV-1亚型和SIVcpz包膜糖蛋白的交叉反应性单克隆抗体。

Cross-reactive monoclonal antibodies to multiple HIV-1 subtype and SIVcpz envelope glycoproteins.

作者信息

Gao Feng, Scearce Richard M, Alam S Munir, Hora Bhavna, Xia Shimao, Hohm Julie E, Parks Robert J, Ogburn Damon F, Tomaras Georgia D, Park Emily, Lomas Woodrow E, Maino Vernon C, Fiscus Susan A, Cohen Myron S, Moody M Anthony, Hahn Beatrice H, Korber Bette T, Liao Hua-Xin, Haynes Barton F

机构信息

Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.

出版信息

Virology. 2009 Nov 10;394(1):91-8. doi: 10.1016/j.virol.2009.07.041. Epub 2009 Sep 9.

DOI:10.1016/j.virol.2009.07.041
PMID:19744690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2785033/
Abstract

The extraordinarily high level of genetic variation of HIV-1 env genes poses a challenge to obtain antibodies that cross-react with multiple subtype Env glycoproteins. To determine if cross-reactive monoclonal antibodies (mAbs) to highly conserved epitopes in HIV-1 envelope glycoproteins can be induced, we immunized mice with wild-type or consensus HIV-1 Env proteins and characterized a panel of ten mAbs that reacted with varying breadth to subtypes A, B, C, D, F, G, CRF01_AE, and a highly divergent SIVcpzUS Env proteins by ELISA and Western blot analysis. Two mAbs (3B3 and 16H3) cross-reacted with all tested Env proteins, including SIVcpzUS Env. Surface plasmon resonance analyses showed both 3B3 and 16H3 bound Env proteins with high affinity. However, neither neutralized primary HIV-1 pseudoviruses. These data indicate that broadly reactive non-neutralizing monoclonal antibodies can be elicited, but that the conserved epitopes that they recognize are not present on functional virion trimers. Nonetheless, such mAbs represent valuable reagents to study the biochemistry and structural biology of Env protein oligomers.

摘要

HIV-1包膜糖蛋白基因的高度遗传变异性给获取能与多种亚型Env糖蛋白发生交叉反应的抗体带来了挑战。为了确定是否能够诱导产生针对HIV-1包膜糖蛋白中高度保守表位的交叉反应性单克隆抗体(mAb),我们用野生型或共有序列的HIV-1 Env蛋白免疫小鼠,并通过ELISA和蛋白质印迹分析对一组10种mAb进行了特性鉴定,这些mAb对A、B、C、D、F、G、CRF01_AE亚型以及一种高度分化的SIVcpzUS Env蛋白表现出不同程度的反应广度。两种mAb(3B3和16H3)与所有测试的Env蛋白发生交叉反应,包括SIVcpzUS Env。表面等离子体共振分析表明,3B3和16H3均以高亲和力结合Env蛋白。然而,二者均不能中和初级HIV-1假病毒。这些数据表明,可以诱导产生具有广泛反应性的非中和性单克隆抗体,但它们识别的保守表位不存在于功能性病毒体三聚体上。尽管如此,此类mAb仍是研究Env蛋白寡聚体生物化学和结构生物学的宝贵试剂。